Steven Shak, Chief Scientific Officer at GENOMIC HEALTH INC (GHDX), sold 100,000 shares at $51.27 ($5.1M) on 2019-06-11, disclosed to the SEC on 2019-06-13.
Seasonal sale ($5.1M) by Chief Scientific Officer — this insider has traded GHDX in June in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $51.27 | 21,298 | $1.1M | 21.3% |
| 2 | $51.27 | 21,298 | $1.1M | 21.3% |
| 3 | $52.33 | 3,702 | $194K | 3.8% |
| 4 | $52.33 | 3,702 | $194K | 3.8% |
| 5 | $51.34 | 25,000 | $1.3M | 25.0% |
| 6 | $51.34 | 25,000 |
| $1.3M |
| 25.0% |
| Total | $51.38 avg | 100,000 | $5.1M | 100% |
| Filing → |
| GHDX | SELL | 2019-08-05 | $3.6M | — | Filing → |
| GHDX | SELL | 2019-07-10 | $2.8M | — | Filing → |
| GHDX | SELL | 2019-06-17 | $3.7M | — | Filing → |